Vitexicarpin is primarily studied for its potential anti-cancer properties. It has shown inhibitory effects on the proliferation of various cancer cell lines, including breast, lung, and liver cancer cells, by inducing cell cycle arrest and promoting apoptosis. Research also indicates that vitexicarpin may possess anti-inflammatory and antioxidant activities, making it a candidate for development in treating chronic inflammatory diseases. Additionally, it has been investigated for its role in modulating signaling pathways such as PI3K/AKT and MAPK, which are involved in cell survival and growth. These biological activities suggest potential applications in pharmaceuticals, particularly in oncology and anti-aging therapies. However, most studies remain in preclinical stages, and further research is needed to evaluate its efficacy and safety in humans.